scholarly article | Q13442814 |
P356 | DOI | 10.1021/JM400963Y |
P698 | PubMed publication ID | 23968485 |
P2093 | author name string | Daniel Bur | |
Daniel Ritz | |||
Peter Seiler | |||
Christopher Kohl | |||
Jean-Philippe Surivet | |||
Marina Dos Santos | |||
Azely Mirre | |||
Christian Hubschwerlen | |||
Cornelia Zumbrunn | |||
Georg Rueedi | |||
Jean-Christophe Gauvin | |||
Michel Enderlin-Paput | |||
Thierry Bruyère | |||
Hans Locher | |||
Wolfgang Keck | |||
Jonathan Delers | |||
Mika Gaertner | |||
Verena Kaegi | |||
Maria Boehme | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7396-7415 | |
P577 | publication date | 2013-09-11 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity | |
P478 | volume | 56 |
Q42150418 | Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing |
Q90739322 | Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV |
Q40356984 | Biophysical Studies of Bacterial Topoisomerases Substantiate Their Binding Modes to an Inhibitor |
Q36933417 | In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus. |
Q40833065 | Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus |
Q41108428 | Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding |
Q64085348 | Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase |
Q37713025 | NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy |
Q27644560 | Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents |
Q36394817 | Structure-based design of novel combinatorially generated NBTIs as potential DNA gyrase inhibitors against various Staphylococcus aureus mutant strains. |
Q41687386 | Target-based resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a novel bacterial type II topoisomerase inhibitor |
Q89573603 | Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs) |
Search more.